Maturity-onset diabetes of the young (MODY) is a monogenic subtype of Type II (non-insulin-dependent) diabetes mellitus characterised by a primary insulin secretory defect and an autosomal-dominant mode of inheritance. We evaluated the effectiveness of fluorescent singlestrand conformation polymorphism (F-SSCP), denaturing high-performance liquid chromatography (DHPLC) and sequencing based mutation detection in the molecular diagnosis of MODY. Our goal is to identify a rapid, efficient and cost effective mutation detection method for the molecular diagnosis of MODY and other human genetic disorders. Methods. We evaluated the accuracy of DHPLC in screening for MODY 2 and 3 mutations. In addition, we compared the sensitivity, specificity, cost, handling time and analysis time of fluorescent single-strand conformation polymorphism, denaturing high-performance liquid chromatography and direct sequencing screening methods.
Results. Denaturing high-performance liquid chromatography is a recently developed method for mutation detection. It is cost effective, powerful and reliable and quite suitable for 22 out of the 24 fragments required for MODY 2 and 3 testing. However, exons 1 and 7 of the HNF-1a gene are very polymorphic and so direct sequencing is faster as well as more efficient and reliable. Conclusion/interpretation. Our results suggest that combining denaturing high-performance liquid chromatography and direct sequencing is a good approach for the routine detection of HNF-1a and GCK mutations in MODY families. Denaturing high-performance liquid chromatography appears to be a powerful tool in genetic testing and the method could be applied to the molecular diagnosis of other human genetic diseases. [Diabetologia (2001) 
44: 775±778]
Keywords Hepatocyte nuclear factor, glucokinase, Maturity-onset diabetes of the young, mutation detection, molecular diagnosis MODY screening. Mutation detection in the HNF1a and GCK genes was performed by fluorescent single-strand conformation polymorphism (F-SSCP) [3] and later by direct sequencing [4] . Although the sensitivity of F-SSCP was high, it did not offer a 100 % detection rate and the false positive rate (5 %) was not negligible. New developments in chemistry (i. e. energy transfer dichloro-rhodamine) allowed the dilution of reagents reducing the cost of sequencing. Although sequencing is accurate for the screening of mutations, it remains expensive and time consuming.
A new mutation detection technique was developed: denaturing high-performance liquid chromatography (DHPLC) [5] discriminating homoduplices and heteroduplices in PCR products by ion pair reverse-phase chromatography under partially denaturing conditions. Its sensitivity is high (96±100 %) compared with denaturing gradient gel electrophoresis, SSCP and gel electrophoresis-based heteroduplex analysis [6, 7] . These reports prompted us to evaluate a DHPLC screening protocol of the HNF-1a and GCK genes. In the context of a routine laboratory we compared fluorescent SSCP, direct sequencing and DHPLC for MODY2 and 3 diagnosis.
Subjects and methods
DNA extraction was performed from EDTA whole-blood samples using the Puregene kit (Gentra, Minneapolis, Minn., USA).
DHPLC protocol. The primers and DHPLC conditions are described in Table 1 . Polymerase chain reactions were performed using AmpliTaq Gold and a Gene-Amp PCR system 9700 thermocycler (Perkin Elmer, Foster city, Calif., USA). The PCR products were denatured at 95 C for 5 min and allowed to cool to 65 C. The DHPLC was performed on a Wave nucleic acid fragment analysis system and DNASep column (Transgenomic, SanJose, Calif., USA). Buffers A and B contained respectively 0.1 mol/l triethylammonium acetate (TEAA) and 0.1 mol/l TEAA, 25 % acetonitrile. Elutions were performed with a mixture of buffers A an B. Initial proportions of buffers and temperature were determined for each PCR fragment (Table 1). Elution was at a flow rate of 0.9 ml/min with a buffer B gradient increase of 2 % per min for a 4 min period.
The time needed for the DHPLC analysis of one sample was 5 min. Homoduplices and heteroduplices were detected by 260 nm absorbance. The sample chromatogram was compared with a reference pattern. If additional or abnormal peak shapes were detected, direct sequencing identified the nucleotide variation.
Quality Control of the column. An important parameter for a successful mutation detection was the quality control of the DNASep column (Transgenomic, SanJose, Calif., USA). Quality control was periodically performed with a standard mutation from a 209 bp fragment (at the DYS271 locus) from Transgenomic. A 1:1 mixture of the wild type and mutant Table 1 . Primer sequences and DHPLC conditions for the molecular screening of the HNF-1a and GCK genes. Theoretical optimal temperatures as determined by the WaveMaker software and those experimentally chosen for optimal detection are reported. All cycling conditions included an initial denaturation at 96 C for 12 min and a final extension for 10 min at 72 C % B, the percentage of buffer B in the elution buffer; bp, base pairs PCR fragments was injected weekly into the DHPLC system. Thus discrimination of heteroduplices and homoduplices was a criteria of reliability for the column. In our experiment, 8000 injections were processed without a loss of efficiency.
Mutation detection by direct sequencing. The protocol was performed using a 3700 DNA sequencer (Applied Biosytems, Foster City, Calif., USA) as previously described [4] .
Results
To evaluate the accuracy of DHPLC, we tested 43 known genetic variants, previously identified by F-SSCP and direct sequencing, in the HNF-1a and GCK genes [2, 3, 8, 9] . DHPLC optimal temperatures (T), critical for suitable detection, were defined with the Wave Maker software. A PCR product from the sample was codenatured with a wild type product and loaded on DHPLC. Primer sequences and DHPLC conditions are reported in Table 1 . All mutations were detected at the temperatures predicted by the WaveMaker software. However, the detection of these mutations was evaluated to be in the range of T-2 C to T + 2 C (i. e. for exon 4 of the HNF1a gene the range was 61 C to 68 C). Thus we selected one or two temperatures presenting the best discrimination between homoduplices and heteroduplices ( Fig. 1) . The results confirmed the high sensitivity of the DHPLC previously described [6, 7] . For PCR fragments with one frequent polymorphism (GCK promoter G > A ±187, intron 9 T > C + 8 or HNF1 a intron 1 G > A ±42, intron 2 C > T ±23, G288G, T515T, intron 9 T > C ±24), a homozygote and a heterozygote PCR product for the polymorphism were loaded as internal controls, thus polymorphisms could be detected on the basis of their characteristic DHPLC profiles even if the retention time was slightly different from one experiment to another (maximal variation of the retention time of 0.1 mins). However, in a second step the sample on its own (without wild type product) was analysed by DHPLC to discriminate between heterozygosity and homozygosity at the relevant polymorphism. The PCR products for exons 1 and 7 of the HNF-1a gene contain respectively 2 and 3 frequent polymorphisms. The various complex haplotypes produced many different profiles. Although DHPLC was able to discriminate the patterns [7] , analysis of these complex DHPLC patterns was time consuming and misinterpretation cannot be excluded. Thus for exons 1 and 7 of the HNF1a gene, molecular screening by direct sequencing appeared faster and more efficient. As included in the optimisation process, the 43 reference polymorphisms were not screened blind. However 25 probands were screened by DHPLC and direct sequencing. 
Discussion
It is noteworthy that, in contrast to F-SSCP, the DHPLC analysis did not require either label or internal fluorescent size standard. The time required for the three methods was 24 hours from 96 genomic DNA samples to the completion of computer data files suitable for analysis. However, DHPLC required less handling time (90 mins) compared with F-SSCP (150 mins) and direct sequencing (165 mins) (Table 2). Moreover the time to look at and score 96 DHPLC patterns (60 mins) was shorter compared with 96 F-SSCP profiles (120 mins) or 96 sequencing files (240 mins). We compared the cost of the methods, including consumables and maintenance of automatic DNA sequencer or DHPLC. The cost of DHPLC (1.2 Euros per fragment analysed) is less than F-SSCP (2 Euros) and direct sequencing (4 Euros). As in our F-SSCP screening protocol [3] , when a suspect DHPLC pattern was detected, direct sequencing was used to ascertain the genetic variation. Because DHPLC produced fewer false positives ( < 1 %) than F-SSCP (5 %), fewer false variants had to be sequenced. Our experience in molecular screening of MODY genes by SSCP and DHPLC is in agreement with the previously reported sensitivities of these methods : 85±95 % for SSCP and 96±100 % for DHPLC [6, 7, 10] . The most sensitive remains sequencing-based detection. If false positives are rare with automatic software analysis of the sequencing data ( < 1 false positive /100 nucleotides) [4] , a precise inspection of forward and reverse profiles allows up to a 100 % sensitivity excluding false positives. Although new sequencing chemistries offer a more cost effective detection of mutation, sequencing remains expensive and the precise analysis of the data is time consuming. Thus the method did not appear satisfactory for a quick and accurate routine genetic testing of large samples.
In conclusion, DHPLC is an efficient tool for the routine diagnosis of human genetic diseases, especially for the detection of heterozygous mutations. The method is cost effective and requires less handling and interpretation time than SSCP or direct sequencing. However, in our study, dye-terminator cycle sequencing appeared more suitable for PCR products containing at least 2 or 3 frequent polymorphisms. A total of 15 patients could be screened per week for HNF1a and GCK genes, with one DHPLC device including PCR, two temperatures DHPLC runs, sequencing of variants and interpretation. An experienced technician requires 10±12 hours/week to perform this screening and interprete the results. The cost of the routine diagnosis of both MODY 2 and MODY 3 genes is 34.4 Euros per sample. Combining DHPLC and direct sequencing screening provides a sensitive, accurate, rapid and lower cost tool for the molecular diagnosis of human genetic disorders. 
